We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 290.00
Ask: 300.00
Change: -10.00 (-3.28%)
Spread: 10.00 (3.448%)
Open: 305.00
High: 305.00
Low: 295.00
Prev. Close: 305.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
1st Nov 20229:25 amRNSTotal Voting Rights
17th Oct 20222:58 pmRNSHolding(s) in Company
12th Oct 20221:00 pmRNSNotice of Third Quarter 2022 Financial Results
3rd Oct 20229:42 amRNSTotal Voting Rights and Block Listing Return
28th Sep 20221:05 pmRNSSigning of Strategic Platform License
21st Sep 20221:05 pmRNSNew Maryland headquarters
8th Sep 20227:00 amRNSMorgan Stanley Healthcare Conference Participation
1st Sep 20224:39 pmRNSTotal Voting Rights
11th Aug 20227:00 amRNSSecond Quarter and Half-Year Results
11th Aug 20227:00 amRNSFiling of Form 10-Q for Second Quarter
2nd Aug 20222:44 pmRNSTotal Voting Rights
20th Jul 202210:00 amRNSChange of Registered Office
15th Jul 20221:01 pmRNSNotice of Results
12th Jul 20221:01 pmRNSSigning of Strategic Platform License
12th Jul 20227:00 amRNSGrant of Options
8th Jul 20225:16 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20227:00 amRNSResult of AGM
17th Jun 20222:51 pmRNSHoldings in Company
6th Jun 20227:00 amRNSPublication of Annual Report
27th May 20227:00 amRNSNotice of AGM
16th May 20227:00 amRNSInducement Grants
10th May 20227:00 amRNSFiling of Form 10-Q
10th May 20227:00 amRNSMaxCyte Reports First Quarter Financial Results
4th May 20227:00 amRNSUpcoming Investor Conferences
29th Apr 20222:41 pmRNSTotal Voting Rights
19th Apr 20227:00 amRNSInducement Grants Under Nasdaq Listing Rule 5635
13th Apr 20227:00 amRNSDeparture of CFO and Preliminary Q1 2022 Revenue
11th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20227:02 amRNSTotal Voting Rights
28th Mar 20221:19 pmRNSGrant of Options and PDMR Dealing
28th Mar 20227:00 amRNSGrant of Options and PDMR Dealing
23rd Mar 20227:00 amRNSFourth Quarter and Full Year Financial Results
10th Mar 20227:00 amRNSMaxCyte, Names Cenk Sumen Chief Scientific Officer
8th Mar 20222:29 pmRNSHolding(s) in Company
3rd Mar 20229:45 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSBlock Listing Return
24th Feb 20221:00 pmRNSNotice of Results
22nd Feb 20223:56 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSConsolidation of Trading Lines
14th Feb 20221:00 pmRNSUpcoming Investor Conferences
14th Feb 20227:00 amRNSInducement Grants Under Nasdaq Listing Rule
1st Feb 20227:00 amRNSLicense with Intima Bioscience
24th Jan 20227:30 amRNSPreliminary Unaudited Q4 & FY 2021 Revenue Results
29th Dec 20213:30 pmRNSHoldings in Company
1st Dec 20215:00 pmRNSTotal Voting Rights
23rd Nov 20217:32 amRNSPurchase of Common Stock
17th Nov 20215:36 pmRNSExercise of options and PDMR Dealing
11th Nov 20217:00 amRNSMaxCyte Reports Third Quarter Financial Results
3rd Nov 20211:00 pmRNSAppointment of Chairman of the Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.